Go offline with the Player FM app!
Deal And Investment Trends With Investment Banker David Sans
Manage episode 475617273 series 2739469
We love to hear from our listeners. Send us a message.
Today we're talking life sciences investment trends and risks with David Sans, an investment banker with an academic background in chemical engineering and molecular modeling, and a professional background that began in Big Pharma and shifted to investing over 15 years ago. Our conversation covers patent cliff implications, hot therapeutic areas and delivery mechanisms, geopolitical risks, alternative funding strategies, and private equity's move upstream to pre-clinical and pre-revenue biotech.
Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [email protected]
Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/
Chapters
1. Deal And Investment Trends With Investment Banker David Sans (00:00:00)
2. Introduction to David Sands (00:00:04)
3. Career Path from Pharma to Finance (00:05:01)
4. Patent Cliff Crisis and M&A Opportunities (00:10:47)
5. Cell Therapies and Regenerative Medicine (00:19:09)
6. Exciting Therapeutic Areas for 2025 (00:27:26)
7. Geopolitical Disruptions and Funding Strategies (00:37:35)
8. Final Thoughts on Industry Collaboration (00:44:53)
255 episodes
Manage episode 475617273 series 2739469
We love to hear from our listeners. Send us a message.
Today we're talking life sciences investment trends and risks with David Sans, an investment banker with an academic background in chemical engineering and molecular modeling, and a professional background that began in Big Pharma and shifted to investing over 15 years ago. Our conversation covers patent cliff implications, hot therapeutic areas and delivery mechanisms, geopolitical risks, alternative funding strategies, and private equity's move upstream to pre-clinical and pre-revenue biotech.
Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com.
Subscribe to our monthly Business of Biotech newsletter.
Get in touch with guest and topic suggestions: [email protected]
Find Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/
Chapters
1. Deal And Investment Trends With Investment Banker David Sans (00:00:00)
2. Introduction to David Sands (00:00:04)
3. Career Path from Pharma to Finance (00:05:01)
4. Patent Cliff Crisis and M&A Opportunities (00:10:47)
5. Cell Therapies and Regenerative Medicine (00:19:09)
6. Exciting Therapeutic Areas for 2025 (00:27:26)
7. Geopolitical Disruptions and Funding Strategies (00:37:35)
8. Final Thoughts on Industry Collaboration (00:44:53)
255 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.